[1]杨卫可,贾瑞平,王明晶,等.抗骨质疏松治疗对膝关节骨性关节炎患者全膝关节置换术后临床疗效的影响[J].新乡医学院学报,2020,37(12):1147-1151.[doi:10.7683/xxyxyxb.2020.12.010]
　YANG Weike,JIA Ruiping,WANG Mingjing,et al.Effect of anti-osteoporosis treatment on clinical efficacy of total knee arthroplastyin patients with knee osteoarthritis[J].Journal of Xinxiang Medical University,2020,37(12):1147-1151.[doi:10.7683/xxyxyxb.2020.12.010]
点击复制

抗骨质疏松治疗对膝关节骨性关节炎患者全膝关节置换术后临床疗效的影响
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年12
页码:
1147-1151
栏目:
临床研究
出版日期:
2020-12-05

文章信息/Info

Title:
Effect of anti-osteoporosis treatment on clinical efficacy of total knee arthroplastyin patients with knee osteoarthritis
作者:
杨卫可; 贾瑞平; 王明晶; 贠　霄; 郭新军
（新乡市中心医院骨科三，河南　新乡　453000）
Author(s):
YANG Weike; JIA Ruiping; WANG Mingjing; YUN Xiao; GUO Xinjun
（Department of Orthopaedics,Xinxiang Central Hospital,Xinxiang 453000，Henan Province，China）
关键词:
骨质疏松; 膝关节骨性关节炎; 全膝关节置换术; 临床疗效
Keywords:
osteoporosis; knee osteoarthritis; total knee arthroplasty; clinical efficacy
分类号:
R684
DOI:
10.7683/xxyxyxb.2020.12.010
文献标志码:
A
摘要:
目的　探讨抗骨质疏松治疗对膝关节骨性关节炎（KOA）患者行全膝关节置换术（TKA）后临床疗效的影响。方法　选择2017年12月至2018年12月在新乡市中心医院行单侧TKA的46例KOA患者为研究对象。根据患者手术前后是否行抗骨质疏松治疗将其分为观察组（n=23）与对照组（n=23），观察组患者术前7 d给予抗骨质疏松药物治疗，连续用药12个月，对照组患者不予以抗骨质疏松药物干预。比较2组患者的临床疗效；分别于术前及术后12个月，采用视觉模拟评分法(VAS)评估患者膝关节疼痛程度，美国西部 Ontario 和 McMaster 大学骨关节炎指数 (WOMAC)评分评估关节炎症反应，Barthel评分评估患者日常生活能力，Fugl-Meyer评分评估患者膝关节运动功能；应用骨密度仪检测2组患者术前及术后12个月腰椎、胫骨近端、股骨远端骨密度；应用酶联免疫吸附法检测2组患者术前及术后12个月关节液中白细胞介素-1β（IL-1β）、肿瘤坏死因子-α（TNF-α）、基质金属蛋白酶-3（MMP-3）、骨钙素水平。结果　观察组和对照组患者的总显效率分别为82.61%（19/23）、52.17%（12/23），观察组患者总显效率显著高于对照组 (P<0.05)。术前2组患者VAS、WOMAC、Barthel、Fugl-Meyer评分比较差异均无统计学意义（P>0.05）； 2组患者术后12个月VAS、WOMAC评分低于术前，Barthel、Fugl-Meyer评分高于术前 (P<0.05)；术后12个月，观察组患者VAS、WOMAC评分显著低于对照组(P<0.05)，Barthel、Fugl-Meyer评分显著高于对照组(P<0.05)。术前2组患者腰椎、胫骨近端、股骨远端骨密度比较差异无统计学意义（P>0.05）；术后12个月，观察组患者腰椎、胫骨近端、股骨远端骨密度高于术前(P<0.05)，对照组患者股骨远端、胫骨近端、腰椎骨密度低于术前(P<0.05)；术后12个月，观察组患者股骨远端、胫骨近端、腰椎骨密度显著高于对照组(P<0.05)。术前2组患者关节液中IL-1β、TNF-α、MMP-3、骨钙素水平比较差异无统计学意义（P>0.05）；术后12个月，2组患者关节液中骨钙素水平高于术前(P<0.05)，IL-1β、TNF-α、MMP-3水平低于术前(P<0.05)；术后12个月，观察组患者关节液中骨钙素水平显著高于对照组(P<0.05)，IL-1β、TNF-α、MMP-3水平显著低于对照组(P<0.05)。结论　行TKA的KOA患者术前、术后应用抗骨质疏松药物治疗可显著增加患者骨密度，减轻术后疼痛及软骨炎症损伤，促进膝关节功能恢复。
Abstract:
Objective　To investigate the effect of anti-osteoporosis treatment on clinical efficacy of total knee arthroplasty (TKA) in patients with knee osteoarthritis (KOA).Methods　Forty patients with KOA who underwent unilateral TKA in Xinxiang Central Hospital from December 2017 to December 2018 were selected as study objects.They were divided into observation group (n=23) and control group (n=23) according to whether they received anti-osteoporosis treatment before and after operation.The patients in the observation group were treated with anti-osteoporosis drugs for 12 months,and the patients in the control group were not given anti-osteoporosis drugs.The curative effect of patients were compared between the two groups.The degree of knee joint pain was evaluated by visual analogue scale (VAS),the inflammatory response of joint was evaluated by western Ontario and McMaster universities osteoarthritis index(WOMAC) score,the ability of daily living of patients was evaluated by Barthel score and the motor function of knee joint was evaluated by Fugl-Meyer score before operation and 12 months after operation.The bone mineral density of lumbar vertebrae,proximal tibia and distal femur was measured by bone densitometer before operation and 12 months after operation.The levels of interleukin-1β (IL-1β),tumor necrosis factor-α (TNF-α),matrix metalloproteinase 3 (MMP-3) and osteocalcin in synovial fluid of patients in the two groups were measured by enzyme linked immunosorbent assay method.Results　The total effective rate of patients in the observation group and the control group was 82.61%(19/23),52.17%(12/23),respectively;the total effective rate of patients in the observation group was significantly higher than that in the control group (P<0.05).There was no significant difference in the VAS,WOMAC,Barthel and Fugl Meyer scores between the two groups before operation (P>0.05);the VAS,WOMAC scores of patients at 12 months after operation were significanlty lower than those before operation,and the Barthel,Fugl Meyer scores were significanlty higher than those before operation in the two groups(P<0.05);the VAS,WOMAC scores of patients in the observation group were significanlty lower than those in the control group,and the Barthel,Fugl Meyer scores were significanlty higher than those in the control group at 12 months after operation (P<0.05).There was no significant difference in the bone mineral density of lumbar vertebrae,proximal tibia and distal femur of patients between the two groups before operation (P>0.05);the bone mineral density of lumbar vertebrae,proximal tibia and distal femur of patients in the observation group at 12 months after operation was significanlty higher than that before operation(P<0.05);the bone mineral density of lumbar vertebrae,proximal tibia and distal femur of patients in the control group at 12 months after operation was significanlty lower than that before operation(P<0.05);the bone mineral density of lumbar vertebrae,proximal tibia and distal femur of patients in the observation group was significanlty higher than that in the control group at 12 months after operation(P<0.05).There was no significant difference in the levels of IL-1β,TNF-α,MMP-3 and osteocalcin in synovial fluid of patients between the two groups before operation(P>0.05);at 12 months after operation,the osteocalcin level in synovial fluid of patients was significanlty higher than that before operation in the two groups,and the IL-1β,TNF-α,MMP-3 levels in synovial fluid of patients were lower than those before operation in the two groups(P<0.05);at 12 months after operation,the osteocalcin level in synovial fluid of patients in the observation group was significanlty higher than that in the control group,and the IL-1β,TNF-α,MMP-3 levels were significanlty lower than those in the control group(P<0.05).Conclusion　The application of the preoperative anti-osteoporosis drugs can increase bone density,reduce postoperative pain and cartilage inflammation,promote knee function recovery of KOA patients undergoing TKA.

参考文献/References:

［1］　MALFAIT A M.Osteoarthritis year in review 2015:biology［J］.Osteoarthritis Cartilage,2016,24(1):21-26.
［2］　LANE N E,SHIDARA K,WISE B L.Osteoarthritis year in review 2016:clinical［J］.Osteoarthritis Cartilage,2017,25(2):209-215.
［3］　FELSON D T,NAIMARK A,ANDERSON J,et al.The prevalence of knee osteoarthritis in the elderly.The framingham osteoarthritis study［J］.Arthritis Rheum,1987,30(8):914-918.
［4］　余铭.微创膝关节置换术治疗膝关节骨性关节炎的疗效及其生活质量的影响［J］.医学理论与实践,2017,30(22):3309-3312.
［5］　仉培武,严少荣.同期和分期双侧TKA治疗双侧膝关节骨关节炎对比研究［J］.临床医学研究与实践,2016,1(17):23-24.
［6］　SOUNDARRAJAN D,RAJKUMAR N,DHANASEKARARAJA P,et al.Proximal tibia stress fracture with osteoarthritis of knee：radiological and functional analysis of one stage TKA with long stem［J］.SICOT J,2018,4(1):13.
［7］　中华医学会风湿病学分会.骨关节炎诊断及诊治指南［J］.中华风湿病学杂志,2010,14(6):416-419.
［8］　邹信明,占卫兵,范乃人.血清CTX-Ⅱ、COMP在关节镜清理术治疗膝骨关节炎前后变化及临床意义［J］.中国医学创新,2016,13(9):13-17.
［9］　FRIMPONG E,MCVEIGH J A,MEIRING R M.Sedentary beha-viour in patients with knee osteoarthritis before and after total knee arthroplasty:a systematic review［J］.J Aging Phys Act,2018,26(4):671-681.
［10］　古东海,张妍,李洁凌,等.膝关节骨性关节炎患者抗骨质疏松治疗对全膝关节置换术后效果影响的临床研究［J］.临床和实验医学杂志,2016,15(11):1093-1095.
［11］　吴春莲,郭江云.密钙息治疗老年骨质疏松症疼痛的观察和心理干预［J］.中国生化药物杂志,2017,37(7):86-87.
［12］　梁建.抗骨质疏松药物辅助治疗膝关节骨性关节炎临床观察［J］.山东医药,2017,57(16):54-56.
［13］　吴波,田卫群.抗骨质疏松治疗对治疗膝骨性关节炎临床疗效的影响［J］.中国中医骨伤科杂志,2013,21(7):27-29.
［14］　曾红俊.膝关节骨性关节炎患者抗骨质疏松治疗对全膝关节置换术后效果影响的临床研究［J］.中国实用医刊,2017,44(3):65-67.
［15］　赖坤聪,罗玉琛,赖炳才,等.膝关节置换术结合中药疗法对膝关节骨性关节炎的临床疗效研究［J］.现代诊断与治疗,2016,27(15):2769-2770.
［16］　王志远,马建兵,肖林,等.依降钙素联合依托考昔对老年骨质疏松患者全膝关节置换术围手术期疼痛及骨代谢指标的影响研究［J］.陕西医学杂志,2018,47(2):253-255.

相似文献/References:

[1]张永喜　高　倩　刘玉府　杨　坤　孔小娟　张静涵　李万里　田玉慧　桂立辉.碳酸钙和生物钙对大鼠废用性骨质疏松症的作用[J].新乡医学院学报,1999,16(04):306.
[2]李亚伟,徐剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[3]李亚伟,徐　剀.两种补钙方式预防孕妇骨质疏松疗效比较[J].新乡医学院学报,2003,20(02):135.
[4]付克广,肖江喜,韩东明。.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[5]田玉慧,娄静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[6]付克广,肖江喜,韩东明.脊柱外伤及原发性骨质疏松椎体压缩的MRI诊断[J].新乡医学院学报,2003,20(03):172.
[7]田玉慧,娄　静,李万里,等.麦胚提取物对去卵巢大鼠骨密度和矿物质的作用[J].新乡医学院学报,2003,20(03):153.
[8]裴凌鹏,崔箭,高兆兰,等.玉米黄质对D-半乳糖致衰老大鼠骨质的影响[J].新乡医学院学报,2008,25(05):436.
[9]刘 菊,梅群超,谢先龙,等.温阳补肾方对去卵巢大鼠骨密度及骨标志物的影响[J].新乡医学院学报,2014,31(06):426.[doi:10.7683/xxyxyxb.2014.06.006]
[10]王红旗.骨水泥弥散状况对骨质疏松性胸腰椎椎体骨折经皮椎体后凸成形术效果的影响[J].新乡医学院学报,2019,36(11):1074.[doi:10.7683/xxyxyxb.2019.11.016]
　WANG Hong-qi.Influence of bone cement dispersion on the effect of percutaneous kyphoplasty in the treatment of osteoporotic thoracolumbar vertebral fracture[J].Journal of Xinxiang Medical University,2019,36(12):1074.[doi:10.7683/xxyxyxb.2019.11.016]

更新日期/Last Update: 2020-12-05